Science claims and predictions

Recent Science claims

• The Global Cloud-Based Drug Discovery Platform Market size is expected to be worth around US$ 10.2 Billion by 2034 from US$ 3.1 Billion in 2024, growing at a CAGR of 12.6% during the forecast period 2025 to 2034.
  By Market.us · Aug 7, 2026
• AI in Cancer Immunotherapy Drugs Market Size to Hit USD ... with CAGR of 24.50% for Target Identification & Validation from 2025-2035
  By Precedence Research · Aug 3, 2026
• AI in Cancer Immunotherapy Drugs Market Size to Hit USD ... with CAGR of 27.60% for Clinical Trial Design & Optimization from 2025-2035
  By Precedence Research · Aug 3, 2026
• Maravai LifeSciences plans to announce its second quarter financial and operating results after the market close on Thursday, August 6, 2026
  By Maravai LifeSciences · Jul 23, 2026
• Digital health venture funding hits $7.4B in first half of 2026
  By Modern Healthcare · Jul 14, 2026
• VC funding for European biotech startups is on track for a record year
  By PitchBook · Jul 14, 2026
• 75% of U.S. health systems use at least one AI application in 2026, up from 59% in 2025
  By Eliciting Insights · Jul 9, 2026
• The FDA approved six orphan drugs in the first half of 2026—leaving the agency just six months to match last year’s total of 30.
  By FDA · Jul 8, 2026
• It would be possible to build an industrially useful quantum computer by 2033
  By Defense Advanced Research Projects Agency · Jul 8, 2026
• an abstract featuring new clinical data on vapendavir -- the company's investigational oral rhinovirus capsid inhibitor -- has been accepted for an oral presentation at the European Respiratory Society (ERS) International Congress 2026 taking place September 5–9, 2026, in Barcelona, Spain.
  By Altesa BioSciences · Jul 7, 2026